Our CSO at the XVII Spanish Drug Discovery Network (SDDN) Meeting 2025
Excited to share that I’ll be participating tomorrow in the XVII Spanish Drug Discovery Network (SDDN) Meeting 2025 in A Coruña!
I’m honored to take part in Session 2: Drug Discovery Stories, where I’ll be giving a talk titled “Transforming rare diseases treatment through novel small molecule therapies”, followed by a round table discussion with fantastic colleagues in the field: Miriam Corredor Sánchez, Javier Terriente and Sonia Martínez Arca
The SDDN Meeting brings together leading experts in drug discovery and translational research, a great opportunity to exchange ideas, foster collaboration, and highlight the importance of innovation in tackling rare neuromuscular and neurodegenerative diseases.
Why it matters
Events like this help accelerate the development of new therapies by connecting scientists, clinicians, and industry partners:
→ Inspiring scientific discussions
→ Real opportunities for collaboration
→ A platform to showcase cutting-edge approaches in drug discovery
When: Tomorrow 14:30, November 20th, 2025, in A Coruña, Spain
Programme: https://lnkd.in/eu5BPRZP
Looking forward to insightful conversations and to sharing Miramoon Pharma’s vision for transforming rare disease treatment through next-generation small molecule therapies.
hashtagSDDN2025 hashtagDrugDiscovery hashtagRareDiseases hashtagNeuroscience hashtagBiotechInnovation hashtagMiramoonPharma hashtagTranslationalResearch hashtagSmallMoleculeTherapeutics
